These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 11898620)
1. [Frequencies of the CCR2-64I and SDF1-3'A alleles associated with progression of the HIV-1 disease in healthy individuals from Moscow]. Riabov GS; Kazennova EV; Bobkov AF Genetika; 2002 Feb; 38(2):278-80. PubMed ID: 11898620 [TBL] [Abstract][Full Text] [Related]
2. Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I alleles) in the Polish population. Lewandowska M; Franciszkiewicz K; Prokop J; Ofori H; Jagodzinski PP J Hum Genet; 2002; 47(11):585-9. PubMed ID: 12436194 [TBL] [Abstract][Full Text] [Related]
3. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians. Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189 [TBL] [Abstract][Full Text] [Related]
4. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China]. Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793 [TBL] [Abstract][Full Text] [Related]
5. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055 [TBL] [Abstract][Full Text] [Related]
6. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population]. Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059 [TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population. Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258 [TBL] [Abstract][Full Text] [Related]
8. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China. Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843 [TBL] [Abstract][Full Text] [Related]
9. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?]. Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924 [TBL] [Abstract][Full Text] [Related]
10. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China]. Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823 [TBL] [Abstract][Full Text] [Related]
11. [Distribution of the HIV-1 resistance-conferring alleles (CCR5delta32, CCR2-64I, and SDF1 3'A) in Russian, Ukrainian, and Belarusian populations]. Kozhekbaeva GM; Borodina TA; Borinskaia SA; Gusar VA; Feshchenko SP; Akhmetova VL; Khusainova RI; Gupalo EIu; Spitsyn VA; Grechanina EIa; Khusnutdinova éK; Iankovskiĭ NK Genetika; 2004 Oct; 40(10):1394-401. PubMed ID: 15575507 [TBL] [Abstract][Full Text] [Related]
12. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations. Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of alleles associated with HIV resistance in Russia. Ryabov GS; Kazennova EV; Bobkova MR; Bobkov AF Genet Test; 2004; 8(1):73-6. PubMed ID: 15140377 [TBL] [Abstract][Full Text] [Related]
14. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese. Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511 [TBL] [Abstract][Full Text] [Related]
15. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type. Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615 [TBL] [Abstract][Full Text] [Related]
16. Spatial genetic structure of two HIV-I-resistant polymorphisms (CCR2-64 I and SDF1-3'A) alleles in population of Shandong Province, China. Xue FZ; Wang JZ; Ma DX; Li GR; Hu P Biomed Environ Sci; 2005 Aug; 18(4):241-53. PubMed ID: 16274106 [TBL] [Abstract][Full Text] [Related]
17. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals. Mazzucchelli R; Corvasce S; Violin M; Riva C; Bianchi R; Dehò L; Velleca R; Cibella J; Bada M; Moroni M; Galli M; Balotta C J Biol Regul Homeost Agents; 2001; 15(3):265-71. PubMed ID: 11693435 [TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression. Daar ES; Lynn HS; Donfield SM; Lail A; O'Brien SJ; Huang W; Winkler CA; J Infect Dis; 2005 Nov; 192(9):1597-605. PubMed ID: 16206074 [TBL] [Abstract][Full Text] [Related]
19. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population. Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715 [TBL] [Abstract][Full Text] [Related]
20. CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy. Passam AM; Zafiropoulos A; Miyakis S; Zagoreos I; Stavrianeas NG; Krambovitis E; Spandidos DA J Clin Virol; 2005 Dec; 34(4):302-9. PubMed ID: 16286054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]